– UK, London – Kingfisher plc (LON: KGF) announced the appointment of Lucinda Riches to its Board of Directors as a Non-Executive Director with effect from 1 January 2025.
Lucinda Riches will also join the Audit, Nomination, Remuneration, and Responsible Business Committees, and should be appointed Chair of the Remuneration Committee at the 2025 AGM, succeeding Rakhi Goss-Custard.
“I am delighted to welcome Lucinda to the Board. She is highly experienced, having served in several roles as a non-executive director, board chair and remuneration committee chair across multiple sectors, following a distinguished senior executive career in investment banking. Her experience will be invaluable as we continue to support our management team to drive Kingfisher’s strategy forward as well as making her an excellent choice to succeed Rakhi as Remuneration Committee chair,” said Board Chair, Claudia Arney.
About Lucinda Riches
Lucinda Riches is the independent Non-Executive Chair of Greencoat UK Wind plc and Peel Hunt Limited. She is also a non-executive director of Ashtead Group plc, where she chairs the remuneration committee. Lucinda has confirmed that she will be stepping down from one of her other listed positions in 2025.
Before becoming a non-executive director, Lucinda Riches had an executive career in investment banking at UBS where she was Global Head of Equity Capital Markets and a member of the board of UBS Investment Bank. Her previous non-executive director roles include CRH plc, ICG Enterprise Trust plc, the British Standards Institution, Diverse Income Trust plc, and UK Financial Investments Ltd.
For more: https://www.kingfisher.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.